Objective Hereditary angioedema (HAE) is a rare genetic disease characterized by long-
term recurrent attacks of subcutaneous or submucosal edema in different parts of the body …

OBJECTIVE: To provide a context to understand the opportunity for novel therapeutic
modalities to transform the treatment of hereditary angioedema (HAE). DATA SOURCES …

Abstract Background The 2010 International Consensus Algorithm for the Diagnosis,
Therapy and Management of Hereditary Angioedema was published earlier this year in this …

The aim of treatment of hereditary angioedema (HAE) due to C1 esterase inhibitor
deficiency (HAE-C1-INH) is either treating acute attacks or preventing attacks by using …

Background Hereditary angioedema (HAE) is a rare disease characterized by
unpredictable, potentially life-threatening attacks, resulting in significant physical and …

Background Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …

BACKGROUND: Hereditary angioedema (HAE) is a potentially life-threatening condition that
affects approximately 1 in 50,000 persons. There are no known surveys of US physicians' …

Hereditary angioedema (HAE) is a rare, chronic disease characterized by debilitating
swelling episodes in various parts Of the body. Patients experience significant burdens …

Hereditary angioedema (HAE) is a rare disease characterized by sudden and often
unprovoked episodes of swelling that can be potentially life-threatening when it involves the …

Hereditary angioedema (HAE) is a rare disease that causes episodic attacks of
subcutaneous and submucosal edema, which can be painful, incapacitating, and potentially …